Connect with us

Health

Inventor of mRNA vaccines ‘concerned’ by reports of excessive uterine bleeding as vaccine side effect

Published

on

July 6, 2021 (LifeSiteNews) — The inventor of the mRNA technology behind at least two of the COVID vaccines has said that he is concerned by the number of women he is hearing from who are reporting excessive uterine bleeding as a vaccine side effect.

In a tweet on July 4, 2021, Dr. Robert Malone said that “heavy flow” uterine bleeding being can actually be the result of an “occult spontaneous abortion,” i.e. a miscarriage which occurs in the early stages of pregnancy, with the woman unaware that she is pregnant.

In another tweet on the same day, Malone again said that he is regularly being contacted hearing from women who have received a COVID vaccine and are now experiencing excessive uterine bleeding. 

Dr. Malone is an internationally recognized scientist in the areas of virology, immunology and molecular biology. He has twenty years of leadership experience in pharmaceutical and biotech industries, academia and government and non-government organizations. He has close to 100 peer-reviewed publications and has recently gained further notoriety as he has begun to publicly question the narrative around distribution of the Covid mRNA vaccine to children.

Malone is not the only one concerned about the rising tide of women reporting menstrual concerns. Both Dr. Katherine Lee, a Postdoctoral Research Fellow in the division of Public Health Services with the Washington University School of Medicine in St. Louis, and fellow colleague Dr. Kathryn Clancy, an associate professor at the University of Illinois Urbana-Champaign, received a COVID jab and experienced abnormal menstrual bleeding. 

Together they have begun further research into the menstrual side-effects of this vaccine. As of April 25, 2021, according to the DailyMail, 25,000 women had responded to their on-line survey and reported stories of disrupted and abnormal menstrual experiences after taking a COVID vaccine.  

In the U.K., the Yellow Card reporting program has logged 2,233 reports of “reproductive and breast disorders” after women have received either the AstraZeneca and Pfizer vaccines. The system reported, as of April 5, 1,465 reactions involving the female reproductive system, 19 “spontaneous abortions,” 5 premature labors, and 2 stillbirths. 

Continue Reading

Health

Hundreds of Indonesian healthcare workers contract COVID-19 despite vaccination, dozens hospitalised

Published

on

JAKARTA: More than 350 Indonesian doctors and healthcare workers have contracted COVID-19 despite being vaccinated with Sinovac and dozens have been hospitalised, officials said, as concerns rise about the efficacy of some vaccines against more virulent virus strains.

Most of the doctors were asymptomatic and self-isolating at home, said Badai Ismoyo, head of the Kudus district health office in Central Java, but dozens were in hospital with high fevers and declining oxygen saturation levels.

Kudus is battling an outbreak believed to be driven by the more transmissible Delta variant which has pushed bed occupancy rates above 90 per cent in the district.

Designated as a priority group, Indonesian healthcare workers were among the first to be vaccinated when the inoculation drive started in January.

Almost all have received the COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac, according to the Indonesian Medical Association.

While the number of Indonesian healthcare workers dying from COVID-19 has decreased significantly – dropping from 158 deaths this January to 13 this May, according to data initiative group LaporCOVID-19 – public health experts say the Java hospitalisations are cause for concern.

“The data shows they have the Delta variant so it is no surprise that the breakthrough infection is higher than before because as we know the majority of healthcare workers in Indonesia got Sinovac, and we still don’t know yet how effective it is in the real world against the Delta variant,” said Dicky Budiman, an epidemiologist from Australia’s Griffith University.

Continue Reading

Health

China’s Covid-19 vaccine flops in Singapore too

Published

on

New Delhi: In a major setback to Chinas Covid vaccines, Singapore is not counting its citizens who received Sinovac Biotech shots as being vaccinated against Covid-19 due to lack of data to show that the doses are effective against coronavirus, especially the Delta strain.

“We don’t really have a medical or scientific basis or have the data now to establish how effective Sinovac is in terms of infection and severe illnesses on Delta,” local media cited health minister Ong Ye Kung as saying at a press conference on Wednesday.

The decision comes close on the heels of serious doubts arising over Chinese vaccines in Indonesia as those who have received the shots are also contracting Covid-19 and infections are surging in the country.

The Delta variant is currently the dominant strain of Covid-19 in Singapore and was identified in the city state in May. Only people who have received the Moderna and Pfizer shots, are being considered as vaccinated in the official records.

Singapore had allowed some private clinics to offer the Sinovac shot, CoronaVac, from mid-June. Around 17,000 people are reported to have received one dose of CoronaVac.

Local media had also reported Singapore’s director of medical services saying last month that evidence from other countries showed people who had taken CoronaVac were still getting infected.

Most of the vaccines being used by Indonesia have also come from China’s Sinovac Biotech. Some health workers inoculated with Sinovac jabs have been hospitalized due to Covid-19. A few have even died despite being fully immunized, according to a report in Nikkei Asia.

The Indonesian Doctors Association says that of the 14 doctors who died from the virus between February and May, ten had been fully vaccinated with Sinovac, while the rest had been given one dose.

Although there is a serious problem with Chinese vaccines due to inadequate data to show their efficacy, some countries are being forced to opt for them because of the cute shortage of vaccines worldwide amid the devastating pandemic.

Continue Reading

Health

102 people qualify for S$451,000 in Covid-19 vaccine injury financial aid to date: Ong Ye Kung

Published

on

SINGAPORE — The authorities have approved S$451,000 worth of financial aid to people who had suffered serious side effects from Covid-19 vaccines in Singapore, Health Minister Ong Ye Kung said on Tuesday (July 6).

The payments have either been paid out or are being processed to 102 applicants under the Vaccine Injury Financial Assistance Programme (Vifap) introduced by the Government in January.

They were among a total of 292 applicants who had submitted a complete Vifap application as of June 25, Mr Ong said.

Of these, 159 did not meet the eligibility criteria and 31 applications are waiting to be reviewed by an independent clinical panel or pending more medical information from the applicant’s doctor.

Mr Ong was responding in a written answer to a parliamentary question filed by Ms He Ting Ru, Member of Parliament for Sengkang Group Representation Constituency, who had asked about the applications made and payments approved under the programme.

TODAY has asked the Ministry of Health (MOH) for details of these approved payouts.

Vifap provides three tiers of support to people assessed to be adversely affected by their Covid-19 inoculation.

The first is a one-time payout of S$2,000 for patients who need hospitalisation and medical intervention and who later recover.

The second is a payout of up to S$10,000 that will be given to those who were hospitalised and required care in a high dependency or intensive care unit, but later recover from the side effects caused by the vaccine.



Continue Reading

Trending